Clofarabine±Fludarabine with Once Daily IV Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS

While a combination of IV busulfan (Bu) and fludarabine (Flu) is a safe, reduced-toxicity conditioning program for AML/MDS, recurrent leukemia post transplantation remains a problem. To enhance the conditioning regimen’s antileukemic effect we decided to supplant Flu with clofarabine (Clo), and assa...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Andersson, Borje S., Valdez, Benigno C., de Lima, Marcos, Wang, Xuemei, Thall, Peter F., Worth, Laura L., Popat, Uday, Madden, Timothy, Hosing, Chitra, Alousi, Amin, Rondon, Gabriela, Kebriaei, Partow, Shpall, Elizabeth J., Jones, Roy B., Champlin, Richard E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3760472/
https://ncbi.nlm.nih.gov/pubmed/20946966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.09.022
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia